Karolinska Development (Sweden) Insiders
| KDEV Stock | SEK 0.29 0.00 0.00% |
Karolinska Development employs about 7 people. The company is managed by 8 executives with a total tenure of roughly 9 years, averaging almost 1.0 years of service per executive, having 0.88 employees per reported executive. Management-performance analysis for Karolinska Development AB gives investors another way to evaluate how leadership is influencing execution, capital allocation, and operating discipline. The practical question is whether leadership is creating repeatable business progress instead of simply managing the narrative around the company.
| Yan Cheng President President Asia |
Karolinska |
Management Team Effectiveness
The company has return on total asset (ROA) of -1.68 % which implies that it generated a $1.68 loss per $100 of asset base. This is below the acceptable range for the industry. Similarly, it shows a return on equity (ROE) of -10.59 %, which indicates that the return on shareholder capital is below zero.Karolinska Development displays a noticeable amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Insider ownership stands at approximately 37% while institutional investors account for 6%, leaving 57% of the float in public hands.
Holders Distribution
Institutional investors in Karolinska Development AB typically operate with more research capacity, technology, and trading scale than retail holders, which is why their activity can materially affect price behavior. Used correctly, the ownership map helps investors see where professional sponsorship may be strong and where exit risk could still be significant.
Workforce Comparison
Karolinska Development AB maintains a fourth standing in number of employees relative to competitors. The total workforce of Health Care industry is now estimated at about 502. Karolinska Development claims roughly 7.0 in number of employees contributing just under 2% to equities under Health Care sector.
Benchmark Summation
Operator |
This analysis covers sixty-one data points across the selected time horizon. Karolinska Development Price Series Summation is a cross summation of Karolinska Development price series and its benchmark/peer.
Notable Stakeholders
A Karolinska Development stakeholder is any individual or group with an interest in the outcome of the business, which is why stakeholder analysis can reveal who may influence strategy and oversight. Used properly, stakeholder review helps investors stay aware of the people and incentives that may be shaping key decisions behind the scenes.
| Yan Cheng | President Asia | Profile | |
| Per Aniansson | Investment Director | Profile | |
| Eva Montgomerie | Head of Accounting | Profile | |
| Johan Dighed | Chief CEO | Profile | |
| Linda Spahiu | Investment Mang | Profile | |
| Hans Toll | Chief Officer | Profile | |
| Viktor MD | Chief Officer | Profile | |
| John MD | Chief Partner | Profile |
Management Information & Data Sources
Karolinska Development is a small-cap company. Executive review focuses on insiders, senior management, and employee signals. Management quality is often reflected indirectly through margin durability, reinvestment choices, and governance signals. CEO is Johan Dighed with 7 employees and 8 reported executives.
Unless otherwise specified, data for Karolinska Development AB is compiled from periodic company reporting and market reference feeds and standardized for comparability. Updates may occur throughout the day. Insider and management fields are mapped from published filings and company disclosures.
This content is curated and reviewed by:
Ellen Johnson - Member of Macroaxis Editorial BoardWorkforce Efficiency and Productivity
Manpower analysis for Karolinska Development AB matters because revenue per employee and profit per employee can reveal shifts in productivity and operating discipline. The business is commonly classified in the Healthcare sector and the Biotechnology industry.
Karolinska Development Manpower Efficiency
Return on Karolinska Development Manpower
| Revenue Per Employee | 310K | |
| Revenue Per Executive | 271.2K | |
| Net Income Per Employee | 24.4M | |
| Net Income Per Executive | 21.4M | |
| Working Capital Per Employee | 35.7M | |
| Working Capital Per Executive | 31.2M |
Additional Tools for Karolinska Stock Analysis
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |